<p>[March 27th Continuous Limit-Up Stock Analysis: Continuous Limit-Up Stock Advancement Rate at 30%, Lithium Battery and Pharmaceutical Sectors Surge Together] Today, a total of 78 stocks hit the limit-up, with 10 continuous limit-up stocks, including 3 stocks with three or more consecutive limit-ups. In the previous trading day, there were 10 continuous limit-up stocks, with an advancement rate of 30% (excluding ST stocks and delisted stocks). In terms of individual stocks, over 4,300 stocks in the entire market rose, with nearly 100 stocks hitting the limit-up or rising over 10%. Short-term sentiment has moderately warmed up, with New Energy Tianshan, Menova, and YOUNGY all advancing to four consecutive limit-ups. High-position stocks performed well; even though the power sector adjusted, high-profile YN Energy Holdings and Zhongnan Culture still rebounded to hit the limit-up, while Huadian Energy achieved 24 consecutive positive days. In terms of sectors, the lithium battery industry chain continued its strong performance from yesterday, with YOUNGY achieving four consecutive limit-ups, Shida Shenghua hitting three limit-ups in six days, and Dandong South achieving two consecutive limit-ups. Lithium mining stocks such as Ganfeng Lithium, Shengxin Lithium Energy, and Yongxing Materials all hit the limit-up in batches. On the news front, Australia, which heavily relies on fuel imports, is facing an oil shortage, raising market concerns that Australian lithium mines may encounter production cuts. The pharmaceutical sector surged strongly throughout the day, with Menova achieving five limit-ups in six days, Wanbangde hitting three limit-ups in four days, and Shuanglu Pharmaceutical achieving two limit-ups in three days. Rejing Bio and Shutaishen both hit the limit-up at 20CM, while nearly ten stocks, including Xinruowei and Yinuosi, rose over 10%</p>

002192

159859

512290

<p>On March 27th, 78 stocks hit the daily limit, with a consecutive limit-up rate of 30%. The lithium battery and pharmaceutical sectors performed strongly, with YOUNGY and several other lithium mining stocks hitting the daily limit. Despite adjustments in the power sector, high-quality stocks still performed well. The pharmaceutical sector also saw significant increases in several individual stocks, indicating an overall improvement in market sentiment</p>

腾讯新闻 - 财经

YOUNGY

Tianhong CNI BIOMEDICINE ETF

Guotai CSI Bio-medicine ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

China Merchants CSI Battery Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

GF CSI HK Innovative Drugs Industry ETF(QDII)

ChinaAMC SSE STAR Biology and Medicine ETF

E Fund CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

E Fund Hang Seng SCHK Innovative Drug ETF

E Fund CSI 300 Health Care ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Fullgoal CSI Battery Theme ETF

Penghua CSI HK Connect Health Care Composite ETF

Bosera Hang Seng Health Care ETF(QDII)

Huaan CSI Subdivision Medicine ETF

Huaan Hang Seng Biotech ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

March 27th Continuous Limit-Up Stock Analysis: Continuous Limit-Up Stock Advancement Rate 30%, Lithium Battery and Pharmaceutical Sectors Surge Together